Recent advances of genomic testing in perinatal medicine

Semin Perinatol. 2015 Feb;39(1):44-54. doi: 10.1053/j.semperi.2014.10.009. Epub 2014 Nov 28.

Abstract

Rapid progress in genomic medicine in recent years has made it possible to diagnose subtle genetic abnormalities in a clinical setting on routine basis. This has allowed for detailed genotype-phenotype correlations and the identification of the genetic basis of many congenital anomalies. In addition to the availability of chromosomal microarray analysis, exome and whole-genome sequencing on pre- and postnatal samples of cell-free DNA has revolutionized the field of prenatal diagnosis. Incorporation of these technologies in perinatal pathology is bound to play a major role in coming years. In this communication, we briefly present the current experience with use of classical chromosome analysis, fluorescence in situ hybridization, and microarray testing, development of whole-genome analysis by next-generation sequencing technology, offer a detailed review of the history and current status of non-invasive prenatal testing using cell-free DNA, and discuss the advents of these new genomic technologies in perinatal medicine.

Publication types

  • Review

MeSH terms

  • Aneuploidy*
  • Female
  • Genetic Counseling
  • Genetic Testing / methods
  • Genetic Testing / trends*
  • Humans
  • In Situ Hybridization, Fluorescence / methods
  • In Situ Hybridization, Fluorescence / trends*
  • Pregnancy
  • Prenatal Diagnosis / methods
  • Prenatal Diagnosis / trends*
  • Reproductive Medicine / trends*